123986-64-1 Usage
Description
(4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER is a chemical compound derived from benzyl carbamic acid, also known as a tert-butyl ester. It is commonly used in organic synthesis and pharmaceutical research due to its versatile properties and potential applications in various industries.
Uses
Used in Organic Synthesis:
(4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a building block in organic synthesis for the creation of various compounds and materials. Its unique structure allows for the formation of new chemical bonds and the development of novel products.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER serves as a key component in the synthesis of various drugs and pharmaceutical products. Its properties make it a valuable precursor for the development of new medications and therapeutic agents.
Used in Plastics Production:
(4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a stabilizer in the production of plastics. Its presence helps to prevent the degradation of plastic materials, enhancing their durability and longevity.
Used in Coatings and Adhesives Manufacturing:
In the manufacturing of coatings and adhesives, (4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER acts as a solvent. Its ability to dissolve other substances allows for the creation of effective coatings and adhesives with improved bonding and performance characteristics.
Used in the Development of New Materials:
(4-HYDROXYMETHYL-BENZYL)-CARBAMIC ACID TERT-BUTYL ESTER may also have potential applications in the development of new materials and compounds for various industrial and scientific purposes. Its unique properties and reactivity make it a promising candidate for further research and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 123986-64-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,3,9,8 and 6 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 123986-64:
(8*1)+(7*2)+(6*3)+(5*9)+(4*8)+(3*6)+(2*6)+(1*4)=151
151 % 10 = 1
So 123986-64-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H19NO3/c1-13(2,3)17-12(16)14-8-10-4-6-11(9-15)7-5-10/h4-7,15H,8-9H2,1-3H3,(H,14,16)
123986-64-1Relevant articles and documents
Supramolecular complexes obtained from porphyrin-crown ether conjugates and a fullerene derivative bearing an ammonium unit
Solladié, Nathalie,Walther, Mathieu E.,Herschbach, Haiko,Leize, Emmanuelle,Dorsselaer, Alain Van,Duarte, Teresa M. Figueira,Nierengarten, Jean-Fran?ois
, p. 1979 - 1987 (2006)
A methanofullerene derivative with an ammonium subunit (1) has been prepared and its ability to form a supramolecular complex with a porphyrin-crown ether conjugate evidenced by NMR, UV-vis, electrospray mass spectrometry (ES-MS) and luminescence experime
Polymer-bound self-folding cavitands
Rafai Far, Adel,Lag Cho, Young,Rang, Alexander,Rudkevich, Dmitry M,Rebek Jr., Julius
, p. 741 - 755 (2002)
The attachment of self-folding cavitands to polymeric supports has been succesfully demonstrated. Crosslinked polystyrene and PEGA were used. The synthesis of cavitands properly functionalized for this purpose is reported. The uptake of quest molecules by the resulting materials and the formation of inclusion complexes on the supports was demonstrated.
CHEMOKINE CXCR4 RECEPTOR MODULATORS AND USES RELATED THERETO
-
Page/Page column 173; 174; 175, (2018/09/19)
The disclosure relates to chemokine CXCR4 receptor modulators and uses related thereto. The receptor modulators can be formulated to form pharmaceutical compositions comprising the disclosed compounds or pharmaceutically acceptable salts or prodrugs thereof. The compositions may be used for managing CXCR4 related conditions, typically prevention or treatment of viral infections abnormal cellular proliferation, retinal degeneration, inflammatory diseases, or as an immunostimulant or immunosuppressant or for managing cancer and may be administered with another active ingredient such as an antiviral agent or chemotherapeutic agent.
HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME
-
Paragraph 0411; 0426; 0427, (2016/12/01)
The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the DESCRIPTION, or a pharmaceutically acceptable salt thereof. The compound has a superior TRPA1 antagonist activity, and can provide a medicament useful for the prophylaxis or treatment of diseases involving TRPA1 antagonist and TRPA1.